🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Treatment Acquiring Popularity Online

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and claims of next-day UK delivery. Sellers market the substance there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Express Worries

Nevertheless, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to individuals injecting substances of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.

Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Content Removal

Based on TikTok, the platform has taken down violative content and banned associated hashtags and query recommendations. The organization stated it was committed to keeping the platform safe and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Research also found communities with up to 9,000 members marketing the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, filled with images of slimming results, glowing reviews and step-by-step guides for preparing or injecting at residence.

Within minutes of entering one community, a seller posted contact information, where the majority of transactions take place. The seller provided an guidebook and promised delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Product Information and Pricing

Inside these groups, messages show black plastic packages with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how long a pen should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her staff has previously seen individuals injured by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to possibly serious medical dangers”.